Literature DB >> 8918585

Structural peculiarities of a truncated V kappa III immunoglobulin light chain in myeloma with light chain deposition disease.

C Decourt1, M Cogné, A Rocca.   

Abstract

We report on the primary sequence of the monoclonal immunoglobulin light chain (LC) REV involved in myeloma-associated light chain deposition disease (LCDD). This sequence was deduced from that of the corresponding complementary (c)DNA in bone marrow plasma cells. Products of three independent amplifications by polymerase chain reaction (PCR) were sequenced and found to be identical. The kappa mRNA encoding this N-glycosylated LC showed an overall normal structure consisting of a V kappa III segment rearranged to J kappa II. Direct N-terminal amino acid sequencing of the circulating monoclonal IgA2, kappa showed identity with the bone marrow-derived sequence. The kappa-chain presented several unusual features affecting both the leader sequence and the variable (V) region. Four unique amino acid substitutions were found at positions -8, -3, -2 and -1 in the leader sequence and probably resulted in an unusual cleavage by signal peptidase, thus making the LC truncated by one residue and accounting for its unique hydrophobic N-terminus: Ile-Ile-Leu. Additional peculiarities were observed in the V region, including a Thr74-->Asn substitution creating a N-glycosylation site, and Thr53-->Ile, which was only reported once among human kappa III chains, in another LCDD case, and may be of special significance at a position usually harbouring a polar amino acid.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918585      PMCID: PMC2200580          DOI: 10.1046/j.1365-2249.1996.d01-841.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Somatic mutations of the L12a gene in V-kappa(1) light chain deposition disease: potential effects on aberrant protein conformation and deposition.

Authors:  R Vidal; F Goñi; F Stevens; P Aucouturier; A Kumar; B Frangione; J Ghiso; G Gallo
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  The effect of paraprotein on platelet aggregation.

Authors:  Irena Djunic; Ivo Elezovic; Vesna Ilic; Nadezda Milosevic-Jovcic; Jelena Bila; Nada Suvajdzic-Vukovic; Darko Antic; Ana Vidovic; Dragica Tomin
Journal:  J Clin Lab Anal       Date:  2014-01-06       Impact factor: 2.352

3.  Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding.

Authors:  H Leibiger; D Wüstner; R D Stigler; U Marx
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

4.  Molecular study of an IgG1kappa cryoglobulin yielding organized microtubular deposits and glomerulonephritis in the course of chronic lymphocytic leukaemia.

Authors:  H R Galea; F Bridoux; J-C Aldigier; F Paraf; D Bordessoule; G Touchard; M Cogné
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

Review 5.  Animal models of monoclonal immunoglobulin-related renal diseases.

Authors:  Christophe Sirac; Guillermo A Herrera; Paul W Sanders; Vecihi Batuman; Sebastien Bender; Maria V Ayala; Vincent Javaugue; Jiamin Teng; Elba A Turbat-Herrera; Michel Cogné; Guy Touchard; Nelson Leung; Frank Bridoux
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

6.  Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease.

Authors:  C Decourt; G Touchard; J L Preud'homme; R Vidal; H Beaufils; M C Diemert; M Cogné
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

7.  Aggregates, crystals, gels, and amyloids: intracellular and extracellular phenotypes at the crossroads of immunoglobulin physicochemical property and cell physiology.

Authors:  Haruki Hasegawa
Journal:  Int J Cell Biol       Date:  2013-03-05

8.  Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis.

Authors:  Stina Enqvist; Knut Sletten; Fred J Stevens; Ulf Hellman; Per Westermark
Journal:  PLoS One       Date:  2007-10-03       Impact factor: 3.240

9.  Indolent systemic mastocytosis associated with light chain deposition disease.

Authors:  Kotaro Sasaki; Alice Chang; Behzad Najafian
Journal:  Clin Kidney J       Date:  2012-10

10.  Light Chain Deposition Disease Diagnosed with Laser Micro-dissection, Liquid Chromatography, and Tandem Mass Spectrometry of Nodular Glomerular Lesions.

Authors:  Tomomichi Kasagi; Hironobu Nobata; Keisuke Suzuki; Naoto Miura; Shogo Banno; Akiyoshi Takami; Taro Yamashita; Yukio Ando; Hirokazu Imai
Journal:  Intern Med       Date:  2017-01-01       Impact factor: 1.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.